Tolvaptan
Ended Awarded
- Contract number
- 36C25220F0326
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,102
Award facts
- Contract value 100% obligated
- $10,102.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 12, awarded a $10,102.19 delivery order to Otsuka America Pharmaceutical Inc. on June 8, 2020, for Tolvaptan, a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. This firm-fixed-price delivery order, which was completed by June 30, 2020, was issued without any set-aside designation and is to be performed in Pittsburgh, Pennsylvania. The contract was executed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), enabling the VA to procure critical pharmaceutical treatments for veterans through an established procurement vehicle.
This delivery order represents one of numerous task orders issued against Otsuka America Pharmaceutical Inc.'s broader Indefinite Delivery Vehicles with the VA, including an $83.3 million Blanket Purchase Agreement for Jynarque (tolvaptan) awarded by the National Acquisition Center through the Federal Supply Schedule, as well as a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology products. These vehicles facilitate streamlined procurement across multiple VA Integrated Service Networks, allowing the healthcare system to efficiently deliver specialized pharmaceutical treatments to veterans nationwide. Otsuka America Pharmaceutical Inc., headquartered in Rockville, Maryland, serves as a key supplier of specialty pharmaceuticals to the Veterans Health Administration and maintains established contracts with multiple VA regions.
Quick answers
Who was awarded contract 36C25220F0326?
36C25220F0326 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on June 8, 2020.
How much is contract 36C25220F0326 worth?
The government has obligated $10,102 on 36C25220F0326.
Is contract 36C25220F0326 an order under another contract?
Yes. 36C25220F0326 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25220F0326 competed?
The extent of competition for 36C25220F0326 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award